Suppr超能文献

肝肾联合移植的单中心经验

Single-center experience of combined liver and kidney transplantation.

作者信息

Kliem V, Ringe B, Frei U, Pichlmayr R

机构信息

Abteilung Nephrologie, Medizinische Hochschule Hannover, Germany.

出版信息

Clin Transplant. 1995 Feb;9(1):39-44.

PMID:7742582
Abstract

Kidney or liver transplantation (KTx, LTx) today is a standard therapeutic procedure if one of these organs fails. However, the need for transplantation of both organs may arise with deterioration of organ function. To evaluate the success of combined LTx/KTx we analyzed 20 patients (aged 14-64) who received a total of 21 LTx and 31 KTx. Simultaneous LTx/KTx was performed in 14 patients, of whom 5 required further replacement of one or the other of the grafted organs. Six patients had sequential transplantation: 3 had LTx prior to the KTx, and 3 KTx prior to LTx. In 12 patients the indication for LTx was end-stage liver cirrhosis, and of these 8 died after LTx, mostly of infections. In a group of 8 transplant recipients without liver cirrhosis (e.g. polycystic liver), only 1 patient died. Eleven of the 20 grafted patients are still alive now (follow-up after LTx 14-120 months). Episodes of liver and kidney rejection occurred in only 30% and 15% of transplanted patients respectively. Only 1 patient is back on hemodialysis, the others have normal liver and kidney function. Combined LTx/KTx may be successful in appropriate circumstances. However, patients with liver cirrhosis have a very poor prognosis due to their poor overall clinical state at the time of terminal renal failure. In contrast, patients without liver cirrhosis are better candidates, even for simultaneous LTx/KTx. In general, the indication for simultaneous organ transplantation should be considered earlier than for transplantation involving only one organ.

摘要

如今,如果肾脏或肝脏其中一个器官功能衰竭,肾移植或肝移植(KTx,LTx)是一种标准的治疗方法。然而,随着器官功能的恶化,可能会出现对两个器官都进行移植的需求。为了评估联合肝移植/肾移植的成功率,我们分析了20例患者(年龄14 - 64岁),他们共接受了21次肝移植和31次肾移植。14例患者接受了同期肝移植/肾移植,其中5例需要进一步更换移植的一个或另一个器官。6例患者进行了序贯移植:3例在肾移植之前进行了肝移植,3例在肝移植之前进行了肾移植。12例患者肝移植的指征是终末期肝硬化,其中8例在肝移植后死亡,主要死于感染。在一组8例无肝硬化的移植受者(如多囊肝)中,只有1例患者死亡。20例接受移植的患者中有11例目前仍然存活(肝移植后随访14 - 120个月)。肝和肾排斥反应分别仅发生在30%和15%的移植患者中。只有1例患者重新开始血液透析,其他患者肝肾功能正常。联合肝移植/肾移植在适当情况下可能会成功。然而,肝硬化患者由于在终末期肾衰竭时整体临床状态较差,预后非常不好。相比之下,没有肝硬化的患者是更好的候选者,即使是同期肝移植/肾移植。一般来说,同期器官移植的指征应比仅涉及一个器官的移植更早考虑。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验